Report cover image

Global Drug modeling software Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Jun 01, 2023
Length 468 Pages
SKU # DAABD18055161

Description

Global Drug modeling software Market - Industry Trends and Forecast to 2030


The drug modeling software market is expected to reach USD 16,808.81 million by 2030 from USD 8,504.35 million in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2033.

Market Segmentation:
Global Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country ( U.S., Canada, Mexico, Germany, France , U.K., Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium,Poland,Sweden, Denmark, Finland, Norway, Rest of Europe, China, Japan , South Korea , India , Australia , Singapore, Thailand , Indonesia , Philippines , Malaysia , New Zealand , Vietnam , Taiwan, Rest Of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa , Saudi Arabia , UAE , Egypt, Israel , Oman , Bahrain , Kuwait , Qatar , Rest of Middle East and Africa - Industry Trends and Forecast to 2030

Overview of Global Drug Modeling Software Market Dynamics:

Driver
• Rising drug discovery and development activities

Restrain

• Lack of quality data base

Opportunity

• Cloud computing and big data analytics in drug modelling

Market Players:

The key market players operating in the drug modeling software market are listed below:

• Dotmatics
• BC Platforms
• InSilicoTrials Technologies.
• VeriSIM Life., Atomwise Inc.
• Certara, USA.
• GENECODE
• Cresset., and Nanome Inc.
• SIMULATIONS PLUS.
• Dassault Systèmes
• Scripps Research
• XtalPi Inc.
• Xybion
• ArgusLab
• Schrödinger, Inc.

Table of Contents

468 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Global Drug Modeling Software Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modeling
2.7 Component Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Market Application Coverage Grid
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
3.1 Porter's Five Forces Model
3.2 Value Chain Analysis
3.3 Regulatory Standards
3.4 Technological Trends
3.5 Benefits Of Drug Modeling Software
4 Market Overview
4.1 Drivers
4.1.1 Rising Drug Discovery And Development Activities
4.1.2 Rising Demand For Novel Therapies
4.1.3 Precision Medicine And Intervention Of Ai In Drug Modelling
4.2 Restraints
4.2.1 Lack Of Quality Data Base
4.2.2 High Cost Of Manufacturing Of Drug Modelling Software
4.3 Opportunities
4.3.1 Cloud Computing And Big Data Analytics In Drug Modelling
4.3.2 Increasing Adoption Of Modelling Tools In Drug Discovery
4.4 Challenges
4.4.1 Lack Of Procedure For Multi-drug Effect Assesment
4.4.2 Challenges With Model Interpretation
5 Global Drug Modeling Software Market, By Components
5.1 Overview
5.1.1 Software
5.1.1.1 Integrated
5.1.1.2 Standalone
5.1.1.3 Ligand Based
5.1.1.4 Structure Based
5.2 Services
5.2.1 Professional Services
5.2.1.1 Consulting And Training
5.2.1.2 Integration And Implementation
5.2.1.3 Support And Maintenance
5.2.2 Managed Services
6 Global Drug Modeling Software Market, By Operating System
6.1 Overview
6.2 Windows
6.3 Linux
6.4 Mac Os
6.5 Others
7 Global Drug Modeling Software Market, By Deployment Mode
7.1 Overview
7.2 Cloud Based
7.3 Hybrid-based
7.4 On-premises
8 Global Drug Modeling Software Market, By Enterprise Size
8.1 Overview
8.2 Large Enterprise Size
8.3 Small & Medium Enterprise Size
9 Global Drug Modeling Software Market, By Application
9.1 Overview
9.2 Graphical Molecular Modeling
9.3 Gene Sequence Analysis
9.4 Protein Modeling
9.5 Modeling Crystal Structures
9.6 Cheminformatics
9.7 High Throughput Virtual Screening
9.8 Gas & Solution Phase Reaction
9.9 Medical Imaging
9.10 Others
10 Global Drug Modeling Software Market, By Purchasing Model
10.1 Overview
10.2 Subscription Based
10.2.1 Annually Subscription
10.2.2 Monthly Subscription
10.3 One-time License
10.3.1 Group License
10.3.2 Desktop License
10.3.3 Others
11 Global Drug Modeling Software Market, By End User
11.1 Overview
11.2 Pharmaceutical & Biotechnology Companies
11.2.1 Large Enterprise Size
11.2.2 Small & Medium Enterprise Size
11.3 Contract Research Organizations
11.3.1 Large Enterprise Size
11.3.2 Small & Medium Enterprise Size
11.4 Research Institutes
11.4.1 Large Enterprise Size
11.4.2 Small & Medium Enterprise Size
11.5 Regulatory Authorities
11.5.1 Large Enterprise Size
11.5.2 Small & Medium Enterprise Size
11.6 Others
11.6.1 Large Enterprise Size
11.6.2 Small & Medium Enterprise Size
12 Global Drug Modeling Software Market, By Region
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 U.K.
12.3.4 Italy
12.3.5 Russia
12.3.6 Spain
12.3.7 Turkey
12.3.8 Netherlands
12.3.9 Switzerland
12.3.10 Belgium
12.3.11 Poland
12.3.12 Sweden
12.3.13 Denmark
12.3.14 Finland
12.3.15 Norway
12.3.16 Rest Of Europe
12.4 Asia-pacific
12.4.1 China
12.4.2 Japan
12.4.3 South Korea
12.4.4 India
12.4.5 Australia
12.4.6 Singapore
12.4.7 Thailand
12.4.8 Indonesia
12.4.9 Philippines
12.4.10 Malaysia
12.4.11 New Zealand
12.4.12 Vietnam
12.4.13 Taiwan
12.4.14 Rest Of Asia-pacific
12.5 South America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest Of South America
12.6 Middle East And Africa
12.6.1 South Africa
12.6.2 Saudi Arabia
12.6.3 U.A.E.
12.6.4 Egypt
12.6.5 Israel
12.6.6 Oman
12.6.7 Bahrain
12.6.8 Kuwait
12.6.9 Qatar
12.6.10 Rest Of Middle East And Africa
13 Global Drug Modeling Software Market: Company Landscape
13.1 Company Share Analysis: Global
13.2 Company Share Analysis: North America
13.3 Company Share Analysis: Europe
13.4 Company Share Analysis: Asia-pacific
14 Swot Analysis
15 Global Drug Modeling Software Market, Company Profile
15.1 Dassault Systemes
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Development
15.2 Amazon Web Services, Inc. Or Its Affiliates.(A Subsidiary Of Amazon)
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Developments
15.3 Certara, Usa.
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Schrödinger, Inc.
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 Cresset.
15.5.1 Company Snapshot
15.5.2 Company Share Analysis
15.5.3 Product Portfolio
15.5.4 Recent Developments
15.6 Acellera Ltd
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Developments
15.7 Arguslab
15.7.1 Company Snapshot
15.7.2 Product Portfolio
15.7.3 Recent Development
15.8 Atomwise Inc.
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Bc Platforms
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Developments
15.10 Biosolveit Gmbh
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Development
15.11 Dotmatics
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Developments
15.12 Genecode
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Development
15.13 Insilicotrials Technologies.
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Developments
15.14 Nanome Inc.
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Optibrium, Ltd.
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Pharmacelera
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Simulations Plus.
15.17.1 Company Snapshot
15.17.2 Revenue Analysis
15.17.3 Company Share Analysis
15.17.4 Product Portfolio
15.17.5 Recent Development
15.18 The Scripps Research Institute
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Development
15.19 Verisim Life.
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Developments
List Of Tables
Table 1 Global Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 2 Global Softaware In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 3 Global Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 4 Global Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 5 Global Services In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 6 Global Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 7 Global Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 8 Global Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 9 Global Windows In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 10 Global Linux In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 11 Global Mac Os In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 12 Global Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 13 Global Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 14 Global Cloud Based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 15 Global Hybrid-based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 16 Global On-premises In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 17 Global Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 18 Global Large Enterprise Size In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 19 Global Small & Medium Enterprise Size In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 20 Global Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 21 Global Graphical Molecular Modeling In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 22 Global Gene Sequence Analysis In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 23 Global Protein Modeling In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 24 Global Modeling Crystal Structures In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 25 Global Cheminformatics In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 26 Global High Throughput Virtual Screening In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 27 Global Gas & Solution Phase Reaction In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 28 Global Medical Imaging In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 29 Global Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 30 Global Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 31 Global Subscription Based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 32 Global Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 33 Global One-time License In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 34 Global One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 35 Global Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 36 Global Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 37 Global Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 38 Global Contract Research Organizations In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 39 Global Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 40 Global Research Institutes In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 41 Global Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 42 Global Regulatory Authorities In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 43 Global Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 44 Global Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 45 Global Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 46 Global Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 47 North America Drug Modeling Software Market, By Country, 2021-2030 (Usd Million)
Table 48 North America Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 49 North America Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 50 North America Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 51 North America Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 52 North America Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 53 North America Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 54 North America Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 55 North America Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 56 North America Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 57 North America Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 58 North America Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 59 North America One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 60 North America Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 61 North America Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 62 North America Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 63 North America Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 64 North America Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 65 North America Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 66 U.S. Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 67 U.S. Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 68 U.S. Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 69 U.S. Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 70 U.S. Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 71 U.S. Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 72 U.S. Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 73 U.S. Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 74 U.S. Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 75 U.S. Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 76 U.S. Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 77 U.S. One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 78 U.S. Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 79 U.S. Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 80 U.S. Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 81 U.S. Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 82 U.S. Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 83 U.S. Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 84 Canada Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 85 Canada Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 86 Canada Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 87 Canada Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 88 Canada Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 89 Canada Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 90 Canada Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 91 Canada Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 92 Canada Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 93 Canada Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 94 Canada Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 95 Canada One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 96 Canada Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 97 Canada Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 98 Canada Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 99 Canada Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 100 Canada Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 101 Canada Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 102 Mexico Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 103 Mexico Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 104 Mexico Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 105 Mexico Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 106 Mexico Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 107 Mexico Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 108 Mexico Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 109 Mexico Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 110 Mexico Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 111 Mexico Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 112 Mexico Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 113 Mexico One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 114 Mexico Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 115 Mexico Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 116 Mexico Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 117 Mexico Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 118 Mexico Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 119 Mexico Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 120 Europe Drug Modeling Software Market, By Country, 2021-2030 (Usd Million)
Table 121 Europe Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 122 Europe Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 123 Europe Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 124 Europe Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 125 Europe Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 126 Europe Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 127 Europe Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 128 Europe Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 129 Europe Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 130 Europe Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 131 Europe Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 132 Europe One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 133 Europe Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 134 Europe Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 135 Europe Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 136 Europe Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 137 Europe Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 138 Europe Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 139 Germany Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 140 Germany Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 141 Germany Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 142 Germany Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 143 Germany Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 144 Germany Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 145 Germany Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 146 Germany Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 147 Germany Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 148 Germany Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 149 Germany Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Global Drug Modeling Software Market: Segmentation
Figure 2 Global Drug Modeling Software Market: Data Triangulation
Figure 3 Global Drug Modeling Software Market: Droc Analysis
Figure 4 Global Drug Modeling Software Market: Global Vs. Regional Market Analysis
Figure 5 Global Drug Modeling Software Market: Company Research Analysis
Figure 6 Global Drug Modeling Software Market: Interview Demographics
Figure 7 Global Drug Modeling Software Market: Multivariate Modeling
Figure 8 Global Drug Modeling Software Market: Dbmr Market Position Grid
Figure 9 Global Drug Modeling Software Market: Vendor Share Analysis
Figure 10 Global Drug Modeling Software Market: Market Application Coverage Grid
Figure 11 Global Drug Modeling Software Market: Segmentation
Figure 12 North America Is Expected To Dominate The Global Drug Modeling Softwaremarket, And Is Expected To Grow With The Highest Cagr In The Forecast Period From 2023 To 2030
Figure 13 Rising Drug Discovery And Development Activities, Rising Demand For Novel Therapies, And Precision Medicine And Intervention Of Ai In Drug Modelling Are Are Expected To Drive The Global Drug Modeling Software Market Growth In The Forecast Period From 2023 To 2030
Figure 14 Software Segment Is Expected To Account For The Largest Share Of The Global Drug Modeling Software Market In 2023 & 2030
Figure 15 North America Is The Fastest-growing Market For The Drug Modeling Software Manufacturers In The Forecast Period From 2023 To 2030
Figure 16 Drivers, Restraints, Opportunities, And Challenges Of The Global Drug Modeling Software Market
Figure 17 Global Drug Modeling Software Market: By Components, 2022
Figure 18 Global Drug Modeling Software Market: By Components, 2023-2030 (Usd Million)
Figure 19 Global Drug Modeling Software Market: By Components, Cagr (2023-2030)
Figure 20 Global Drug Modeling Software Market: By Components, Lifeline Curve
Figure 21 Global Drug Modeling Software Market: By Operating System, 2022
Figure 22 Global Drug Modeling Software Market: By Operating System, 2023-2030 (Usd Million)
Figure 23 Global Drug Modeling Software Market: By Operating System, Cagr (2023-2030)
Figure 24 Global Drug Modeling Software Market: By Operating System, Lifeline Curve
Figure 25 Global Drug Modeling Software Market: By Deployment Mode, 2022
Figure 26 Global Drug Modeling Software Market: By Deployment Mode, 2023-2030 (Usd Million)
Figure 27 Global Drug Modeling Software Market: By Deployment Mode, Cagr (2023-2030)
Figure 28 Global Drug Modeling Software Market: By Deployment Mode, Lifeline Curve
Figure 29 Global Drug Modeling Software Market: By Enterprise Size, 2022
Figure 30 Global Drug Modeling Software Market: By Enterprise Size, 2023-2030 (Usd Million)
Figure 31 Global Drug Modeling Software Market: By Enterprise Size, Cagr (2023-2030)
Figure 32 Global Drug Modeling Software Market: By Enterprise Size, Lifeline Curve
Figure 33 Global Drug Modeling Software Market: By Application, 2022
Figure 34 Global Drug Modeling Software Market: By Application, 2023-2030 (Usd Million)
Figure 35 Global Drug Modeling Software Market: By Application, Cagr (2023-2030)
Figure 36 Global Drug Modeling Software Market: By Application, Lifeline Curve
Figure 37 Global Drug Modeling Software Market: By Purchasing Model, 2022
Figure 38 Global Drug Modeling Software Market: By Purchasing Model, 2023-2030 (Usd Million)
Figure 39 Global Drug Modeling Software Market: By Purchasing Model, Cagr (2023-2030)
Figure 40 Global Drug Modeling Software Market: By Purchasing Model, Lifeline Curve
Figure 41 Global Drug Modeling Software Market: By End User, 2022
Figure 42 Global Drug Modeling Software Market: By End User, 2023-2030 (Usd Million)
Figure 43 Global Drug Modeling Software Market: By End User, Cagr (2023-2030)
Figure 44 Global Drug Modeling Software Market: By End User, Lifeline Curve
Figure 45 Global Drug Modeling Software Market: Snapshot (2022)
Figure 46 Global Drug Modeling Software Market: By Region (2022)
Figure 47 Global Drug Modeling Software Market: By Region (2023 & 2030)
Figure 48 Global Drug Modeling Software Market: By Region (2022 & 2030)
Figure 49 Global Drug Modeling Software Market: By Components (2023-2030)
Figure 50 North America Drug Modeling Software Market: Snapshot (2022)
Figure 51 North America Drug Modeling Software Market: By Country (2022)
Figure 52 North America Drug Modeling Software Market: By Country (2023 & 2030)
Figure 53 North America Drug Modeling Software Market: By Country (2022 & 2030)
Figure 54 North America Drug Modeling Software Market: By Components (2023-2030)
Figure 55 Europe Drug Modeling Software Market: Snapshot (2022)
Figure 56 Europe Drug Modeling Software Market: By Country (2022)
Figure 57 Europe Drug Modeling Software Market: By Country (2023 & 2030)
Figure 58 Europe Drug Modeling Software Market: By Country (2022 & 2030)
Figure 59 Europe Drug Modeling Software Market: By Components (2023-2030)
Figure 60 Asia-pacific Drug Modeling Software Market: Snapshot (2022)
Figure 61 Asia-pacific Drug Modeling Software Market: By Country (2022)
Figure 62 Asia-pacific Drug Modeling Software Market: By Country (2023 & 2030)
Figure 63 Asia-pacific Drug Modeling Software Market: By Components (2023-2030)
Figure 64 South America Drug Modeling Software Market: Snapshot (2022)
Figure 65 South America Drug Modeling Software Market:

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us